Serum levels of Gal-3 were significantly higher in COVID-19 patients compared with healthy controls (16.7 [13.2-31.5] ng/mL vs. 11.1 [8.5-13.6] ng/mL; P<0.001). This evidence concerns the gene LGALS3 and COVID-19.